1
|
Kaliampou S, Nikolaou V, Niforou A, Kotsiopoulou I, Gerochristou M, Papanikolaou A, Kanellis G, Papadavid E, Tsimpidakis A, Pouliou E, Economaki E, Panou E, Nikolaou C, Stratigos AJ, Naska A, Marinos L. Epidemiological trends in cutaneous lymphomas in Greece. Eur J Dermatol 2023; 33:664-673. [PMID: 38465548 DOI: 10.1684/ejd.2023.4617] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/12/2024]
Abstract
Primary cutaneous lymphomas (PCLs) are a heterogenous group of non-Hodgkin lymphomas arising in the skin from T- or B-lymphocytes, for which there is limited epidemiological data available. To describe the disease characteristics and estimate annual incidence rates (IRs) and temporal trends of PCLs and their subtypes in Attica, Greece. A retrospective analysis of all PCL patients, diagnosed in Attica's main haemopathology referral centre from 2009 to 2021, was conducted. In total, 1,189 patients were included; 725 males and 464 females (males__females=1.56). The median age at diagnosis was 62 years. The annual IR was 2.2 new cases per 100,000 individuals. Most patients (n=979, 82.3%) were diagnosed with cutaneous T-cell lymphoma (CTCL) with a crude IR of 1.8 new cases per 100,000 person-years. Mycosis fungoides (MF) was the most common subtype (n=817, 68.7%), followed by lymphomatoid papulosis (LyP) (n=59, 5.0%). The crude IR for MF was 1.5 new cases per 100,000 person-years. Cutaneous B-cell lymphomas (CBCLs) accounted for 17.6% (n=210) of all PCLs (IR: 0.4 new cases per 100,000 person-years). PCL, CTCL and MF incidence rates increased from 2009 to 2019, followed by a decrease in 2020-2021. The incidence rate of CBCL increased steadily during the study period. The annual IRs of PCL in Greece were higher than those reported in other studies from Europe, America and Asia. The increase in IRs from 2009 to 2019 may reflect physicians' improved diagnostic efficiency. The COVID-19 pandemic may be the reason for the decline in PCL, CTCL and MF diagnoses from 2020 to 2021.
Collapse
Affiliation(s)
- Stella Kaliampou
- 1st Department of Dermatology and Venereology, Cutaneous Lymphoma Clinic, National and Kapodistrian University of Athens, "Andreas Sygros" Hospital of Venereal and Skin Diseases, Athens, Greece
| | - Vasiliki Nikolaou
- 1st Department of Dermatology and Venereology, Cutaneous Lymphoma Clinic, National and Kapodistrian University of Athens, "Andreas Sygros" Hospital of Venereal and Skin Diseases, Athens, Greece
| | - Aikaterini Niforou
- 1st Department of Dermatology and Venereology, Cutaneous Lymphoma Clinic, National and Kapodistrian University of Athens, "Andreas Sygros" Hospital of Venereal and Skin Diseases, Athens, Greece, Department of Hygiene, Epidemiology and Medical Statistics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece
| | - Ioanna Kotsiopoulou
- 1st Department of Dermatology and Venereology, Cutaneous Lymphoma Clinic, National and Kapodistrian University of Athens, "Andreas Sygros" Hospital of Venereal and Skin Diseases, Athens, Greece
| | - Maria Gerochristou
- 1st Department of Dermatology and Venereology, Cutaneous Lymphoma Clinic, National and Kapodistrian University of Athens, "Andreas Sygros" Hospital of Venereal and Skin Diseases, Athens, Greece
| | | | - Georgios Kanellis
- Hematopathology Department, "Evangelismos" General Hospital, Athens, Greece
| | - Evangelia Papadavid
- 2nd Department of Dermatology and Venereology, National and Kapodistrian University of Athens, "Attikon" University General Hospital, Athens, Greece, ERNBloodNet centre for cutaneous lymphomas
| | - Antonios Tsimpidakis
- 1st Department of Dermatology and Venereology, Cutaneous Lymphoma Clinic, National and Kapodistrian University of Athens, "Andreas Sygros" Hospital of Venereal and Skin Diseases, Athens, Greece
| | - Evdoxia Pouliou
- Hematopathology Department, "Evangelismos" General Hospital, Athens, Greece
| | - Elisavet Economaki
- Hematopathology Department, "Evangelismos" General Hospital, Athens, Greece
| | - Evdoxia Panou
- 1st Department of Dermatology and Venereology, Cutaneous Lymphoma Clinic, National and Kapodistrian University of Athens, "Andreas Sygros" Hospital of Venereal and Skin Diseases, Athens, Greece
| | | | - Alexander J Stratigos
- 1st Department of Dermatology and Venereology, Cutaneous Lymphoma Clinic, National and Kapodistrian University of Athens, "Andreas Sygros" Hospital of Venereal and Skin Diseases, Athens, Greece
| | - Androniki Naska
- Department of Hygiene, Epidemiology and Medical Statistics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece
| | - Leonidas Marinos
- Hematopathology Department, "Evangelismos" General Hospital, Athens, Greece
| |
Collapse
|
2
|
Theodorakakou F, Fotiou D, Spiliopoulou V, Roussou M, Malandrakis P, Ntanasis-Stathopoulos I, Migkou M, Eleutherakis-Papaiakovou E, Kanellias N, Papanikolaou A, Gavriatopoulou M, Terpos E, Dimopoulos MA, Kastritis E. Outcomes of patients with light chain (AL) amyloidosis after failure of daratumumab-based therapy. Br J Haematol 2023; 203:411-415. [PMID: 37580907 DOI: 10.1111/bjh.19042] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/28/2023] [Revised: 07/01/2023] [Accepted: 08/03/2023] [Indexed: 08/16/2023]
Abstract
As daratumumab use in AL amyloidosis increases, more patients will either relapse after or become refractory to daratumumab. We present the outcome of 33 patients with AL who failed on daratumumab (due to haematological relapse in 21 [64%] patients and inadequate haematological response in 12 [36%]) and received further treatment. Overall response rate in the post-daratumumab failure treatment was 55% (CR/VGPR: 14 [42%] and PR: 3 [9%] patients). Patients retreated with daratumumab and patients harbouring +1q21 had lower rates of response. Treatment of patients with AL who fail daratumumab therapy is feasible when non-cross-resistant drugs or other targeted therapies are available.
Collapse
Affiliation(s)
- Foteini Theodorakakou
- Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
| | - Despina Fotiou
- Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
| | - Vasiliki Spiliopoulou
- Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
| | - Maria Roussou
- Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
| | - Panagiotis Malandrakis
- Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
| | - Ioannis Ntanasis-Stathopoulos
- Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
| | - Magdalini Migkou
- Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
| | | | - Nikolaos Kanellias
- Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
| | | | - Maria Gavriatopoulou
- Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
| | - Evangelos Terpos
- Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
| | - Meletios A Dimopoulos
- Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
| | - Efstathios Kastritis
- Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
| |
Collapse
|
3
|
Fotiou D, Theodorakakou F, Gavriatopoulou M, Migkou M, Malandrakis P, Ntanasis-Stathopoulos I, Kanellias N, Eleutherakis Papaiakovou E, Terpos E, Papanikolaou A, Gakiopoulou C, Dimopoulos MA, Kastritis E. Prognostic impact of translocation t(11;14) and of other cytogenetic abnormalities in patients with AL amyloidosis in the era of contemporary therapies. Eur J Haematol 2023. [PMID: 37218632 DOI: 10.1111/ejh.13993] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/23/2023] [Revised: 05/02/2023] [Accepted: 05/04/2023] [Indexed: 05/24/2023]
Abstract
OBJECTIVES Translocation t(11;14) is the most common cytogenetic abnormality in patients with systemic AL amyloidosis with prognostic and therapeutic relevance, which has not been clearly defined in the most recent therapeutic era. METHODS We assessed its prognostic role in 146 newly-diagnosed patients who received novel agent-based treatment combinations. Event-free survival (EFS), a composite endpoint defined by hematological progression, start of a new treatment-line or death, and overall survival (OS) were the primary endpoints. RESULTS Half of the patients had at least one FISH abnormality; 40% had t(11;14) which was inversely associated with other cytogenetic abnormalities. At 1, 3, and 6-month landmarks, hematologic response rates were numerically but not statistically higher in the non-t(11;14) group. Patients with t(11;14) were more frequently switched to second-line treatment within 12 months (p = .015). At median follow-up of 31.4 months, t(11;14) was associated with shorter EFS [17.1 (95% CI 3.2-10.6) vs. 27.2 months (95% CI 13.8-40.6), p = .021] and retained its prognostic significance in the multivariate model (HR:1.66, p = .029). The effect on OS was neutral, possibly due to the use of effective salvage therapies. CONCLUSIONS Our data support the use of targeted therapies for patients with t(11;14) to avoid delays in the achievement of deep hematologic responses.
Collapse
Affiliation(s)
- Despina Fotiou
- Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece
| | - Foteini Theodorakakou
- Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece
| | - Maria Gavriatopoulou
- Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece
| | - Magdalini Migkou
- Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece
| | - Panagiotis Malandrakis
- Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece
| | | | - Nikolaos Kanellias
- Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece
| | | | - Evangelos Terpos
- Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece
| | | | - Charikleia Gakiopoulou
- First Department of Pathology, National and Kapodistrian University of Athens, Athens, Greece
| | | | - Efstathios Kastritis
- Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece
| |
Collapse
|
4
|
Fotiou D, Theodorakakou F, Malandrakis P, Ntanasis-Stathopoulos I, Gavriatopoulou M, Kanellias N, Migkou M, Eleutherakis-Papaiakovou E, Papanikolaou A, Gakiopoulou C, Terpos E, Dimopoulos MA, Kastritis E. Patterns of target organ amyloid deposition in patients with AL amyloidosis; role for diagnosis and prognosis. Leuk Lymphoma 2023:1-4. [PMID: 37035896 DOI: 10.1080/10428194.2023.2197537] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/11/2023]
Affiliation(s)
- Despina Fotiou
- Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Attica, Greece
| | - Foteini Theodorakakou
- Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Attica, Greece
| | - Panagiotis Malandrakis
- Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Attica, Greece
| | | | - Maria Gavriatopoulou
- Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Attica, Greece
| | - Nikolaos Kanellias
- Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Attica, Greece
| | - Magdalini Migkou
- Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Attica, Greece
| | | | | | - Charikleia Gakiopoulou
- 1st Department of Pathology, National and Kapodistrian University of Athens, Athens, Greece
| | - Evangelos Terpos
- Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Attica, Greece
| | | | - Efstathios Kastritis
- Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Attica, Greece
| |
Collapse
|
5
|
Vatopoulou A, Margioula-Siarkou C, Papanikolaou A. 118 Contraception practice and knowledge of IUD among teenagers and young women. Eur J Obstet Gynecol Reprod Biol 2022. [DOI: 10.1016/j.ejogrb.2022.02.147] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
6
|
Vatopoulou A, Daniilidis A, Dampali R, Fotas A, Papanikolaou A, Dinas K. 402 A case of acute renal failure from bilateral ureteral obstruction due to endometriosis. Eur J Obstet Gynecol Reprod Biol 2022. [DOI: 10.1016/j.ejogrb.2021.11.090] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
7
|
Stergiou IE, Chatzis L, Papanikolaou A, Giannouli S, Tzioufas AG, Voulgarelis M, Kapsogeorgou EK. Akt Signaling Pathway Is Activated in the Minor Salivary Glands of Patients with Primary Sjögren's Syndrome. Int J Mol Sci 2021; 22:ijms222413441. [PMID: 34948236 PMCID: PMC8709495 DOI: 10.3390/ijms222413441] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/22/2021] [Revised: 12/08/2021] [Accepted: 12/13/2021] [Indexed: 11/16/2022] Open
Abstract
Primary Sjögren's syndrome (pSS) is an autoimmune exocrinopathy of mainly the salivary and lacrimal glands associated with high prevalence of lymphoma. Akt is a phosphoinositide-dependent serine/threonine kinase, controlling numerous pathological processes, including oncogenesis and autoimmunity. Herein, we sought to examine its implication in pSS pathogenesis and related lymphomagenesis. The expression of the entire and activated forms of Akt (partially and fully activated: phosphorylated at threonine-308 (T308) and serine-473 (S473), respectively), and two of its substrates, the proline-rich Akt-substrate of 40 kDa (PRAS40) and FoxO1 transcription factor has been immunohistochemically examined in minor salivary glands (MSG) of pSS patients (n = 29; including 9 with pSS-associated lymphoma) and sicca-complaining controls (sicca-controls; n = 10). The entire and phosphorylated Akt, PRAS40, and FoxO1 molecules were strongly, uniformly expressed in the MSG epithelia and infiltrating mononuclear cells of pSS patients, but not sicca-controls. Morphometric analysis revealed that the staining intensity of the fully activated phospho-Akt-S473 in pSS patients (with or without lymphoma) was significantly higher than sicca-controls. Akt pathway activation was independent from the extent or proximity of infiltrates, as well as other disease features, including lymphoma. Our findings support that the Akt pathway is specifically activated in MSGs of pSS patients, revealing novel therapeutic targets.
Collapse
Affiliation(s)
- Ioanna E. Stergiou
- Department of Pathophysiology, School of Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece; (I.E.S.); (L.C.); (A.G.T.); (M.V.)
| | - Loukas Chatzis
- Department of Pathophysiology, School of Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece; (I.E.S.); (L.C.); (A.G.T.); (M.V.)
| | | | - Stavroula Giannouli
- Hematology Unit, Second Department of Internal Medicine, School of Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece;
| | - Athanasios G. Tzioufas
- Department of Pathophysiology, School of Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece; (I.E.S.); (L.C.); (A.G.T.); (M.V.)
| | - Michael Voulgarelis
- Department of Pathophysiology, School of Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece; (I.E.S.); (L.C.); (A.G.T.); (M.V.)
| | - Efstathia K. Kapsogeorgou
- Department of Pathophysiology, School of Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece; (I.E.S.); (L.C.); (A.G.T.); (M.V.)
- Correspondence: ; Tel.: +30-210-746-2670
| |
Collapse
|
8
|
Karanikas I, Karayiannis D, Kournidakis A, Papanikolaou A, Mastora Z, Almperti A, Katsagoni C, Chourdakis M, Kakavas S. Increased waist circumference as a predictor of outcome among hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease. Clin Nutr ESPEN 2021. [DOI: 10.1016/j.clnesp.2021.09.169] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
9
|
Kastritis E, Rousakis P, Kostopoulos IV, Gavriatopoulou M, Theodorakakou F, Fotiou D, Dialoupi I, Migkou M, Roussou M, Kanellias N, Tselegkidi MI, Eleutherakis-Papaiakovou E, Papanikolaou A, Gakiopoulou C, Psimenou E, Spyropoulou-Vlachou M, Gatou A, Terpos E, Tsitsilonis O, Dimopoulos MA. Consolidation with a short course of daratumumab in patients with AL amyloidosis or light chain deposition disease. Amyloid 2021; 28:259-266. [PMID: 34468250 DOI: 10.1080/13506129.2021.1971192] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Abstract
Daratumumab has major and rapid activity in AL amyloidosis with favourable toxicity. We used as a consolidation a short course of daratumumab in 25 patients with AL amyloidosis or light chain deposition disease (LCDD), who had not achieved a haematologic complete response (hemCR) after standard therapy with bortezomib, cyclophosphamide and dexamethasone (VCD). We evaluated minimal residual disease (MRD) and changes in the bone marrow (BM) microenvironment before and after consolidation using next generation flow cytometry (NGF). At the time of consolidation, 21 patients were in very good partial response (VGPR) and four in partial response (PR); all had detectable MRD. One month after consolidation completion, 8 patients (32%) achieved a hemCR, of whom 5 (20%) became also MRD negative. In the BM, we observed significant changes in B-cell precursors, naïve B-cells, T-cells, CD27+ NK & NKT cells, mast cells and erythroblasts. After a median follow-up of 25 months, none of the patients in hemCR has relapsed and all have achieved an organ response; a haematologic relapse occurred in 6/17 patients that did not achieve hemCR. In conclusion, consolidation with a short course of daratumumab can improve depth of response in patients with AL amyloidosis or LCDD and significantly affects BM environment.
Collapse
Affiliation(s)
- Efstathios Kastritis
- Plasma Cell Dyscrasia Unit, Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece
| | - Pantelis Rousakis
- Department of Biology, National and Kapodistrian University of Athens, Athens, Greece
| | - Ioannis V Kostopoulos
- Department of Biology, National and Kapodistrian University of Athens, Athens, Greece
| | - Maria Gavriatopoulou
- Plasma Cell Dyscrasia Unit, Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece
| | - Foteini Theodorakakou
- Plasma Cell Dyscrasia Unit, Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece
| | - Despina Fotiou
- Plasma Cell Dyscrasia Unit, Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece
| | - Ioanna Dialoupi
- Plasma Cell Dyscrasia Unit, Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece
| | - Magdalini Migkou
- Plasma Cell Dyscrasia Unit, Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece
| | - Maria Roussou
- Plasma Cell Dyscrasia Unit, Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece
| | - Nikolaos Kanellias
- Plasma Cell Dyscrasia Unit, Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece
| | - Maria-Irini Tselegkidi
- Plasma Cell Dyscrasia Unit, Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece
| | | | | | - Charikleia Gakiopoulou
- 1st Department of Pathology, National and Kapodistrian University of Athens, Athens, Greece
| | - Erasmia Psimenou
- Plasma Cell Dyscrasia Unit, Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece
| | | | | | - Evangelos Terpos
- Plasma Cell Dyscrasia Unit, Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece
| | - Ourania Tsitsilonis
- Department of Biology, National and Kapodistrian University of Athens, Athens, Greece
| | - Meletios A Dimopoulos
- Plasma Cell Dyscrasia Unit, Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece
| |
Collapse
|
10
|
Sidiropoulou P, Marinos L, Gerochristou M, Economaki E, Papanikolaou A, Voudouri D, Kalliambou S, Stratigos A, Nikolaou V. Topical mechlorethamine in mycosis fungoides: a prospective clinical, histopathological, and molecular analysis of 13 cases. Eur J Cancer 2021; 156 Suppl 1:S61-S62. [PMID: 34649665 DOI: 10.1016/s0959-8049(21)00742-5] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Affiliation(s)
- Polytimi Sidiropoulou
- 1st Department of Dermatology-Venereology, Faculty of Medicine, National and Kapodistrian University of Athens, "A. Sygros" Hospital for Skin and Venereal Diseases, Athens, Greece
| | - Leonidas Marinos
- Hemopathology Department, "Evangelismos" General Hospital, Athens, Greece
| | - Maria Gerochristou
- 1st Department of Dermatology-Venereology, Faculty of Medicine, National and Kapodistrian University of Athens, "A. Sygros" Hospital for Skin and Venereal Diseases, Athens, Greece
| | | | | | - Dimitra Voudouri
- 1st Department of Dermatology-Venereology, Faculty of Medicine, National and Kapodistrian University of Athens, "A. Sygros" Hospital for Skin and Venereal Diseases, Athens, Greece
| | - Styliani Kalliambou
- 1st Department of Dermatology-Venereology, Faculty of Medicine, National and Kapodistrian University of Athens, "A. Sygros" Hospital for Skin and Venereal Diseases, Athens, Greece
| | - Alexander Stratigos
- 1st Department of Dermatology-Venereology, Faculty of Medicine, National and Kapodistrian University of Athens, "A. Sygros" Hospital for Skin and Venereal Diseases, Athens, Greece
| | - Vasiliki Nikolaou
- 1st Department of Dermatology-Venereology, Faculty of Medicine, National and Kapodistrian University of Athens, "A. Sygros" Hospital for Skin and Venereal Diseases, Athens, Greece
| |
Collapse
|
11
|
Kaliampou S, Nikolaou V, Kotsiopoulou I, Papanikolaou A, Voudouri D, Papadavid E, Kanellis G, Pouliou E, Oikonomaki E, Gerochristou M, Stratigos A, Marinos L. Epidemiology of primary cutaneous lymphomas in Greece: a 12-year retrospective study. Eur J Cancer 2021. [DOI: 10.1016/s0959-8049(21)00753-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
12
|
Giotis I, Tribonias G, Zacharopoulou E, Palatianou M, Leontidis N, Pantoula P, Vogiatzi G, Bakasis AD, Papanikolaou A, Tzouvala M. A rare case of duodenal-type follicular lymphoma in rectum appearing as hyperplastic polyp with metachronous appearance in duodenum and stomach. Clin J Gastroenterol 2021; 14:1632-1636. [PMID: 34453280 DOI: 10.1007/s12328-021-01501-8] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/06/2021] [Accepted: 08/11/2021] [Indexed: 11/25/2022]
Abstract
Hyperplastic polyps consist a very frequent finding in colonoscopy having a very low potential to malignancy. According to the international guidelines, it is recommended that all polyps should be resected except for diminutive (≤ 5 mm) rectal and rectosigmoid polyps which are predicted with confidence to be hyperplastic. Therefore, in departments where optical diagnosis can be ensured, a "resect and discard" strategy may be implemented for diminutive polyps. In our case, a duodenal-type follicular lymphoma was detected in a 5 mm rectum polyp with hyperplastic appearance. After 4 months, the lymphoma was detected also in stomach and duodenum. Under therapy with Rituximab, she is in remission. To our knowledge, there has never been reported such a case in the literature. Furthermore, it alerts us that we should be very cautious with the optical diagnosis and the "resect and discard strategy".
Collapse
Affiliation(s)
- Ioannis Giotis
- Department of Gastroenterology, General Hospital of Nikea-Piraeus 'Agios Panteleimon', Athens, Greece.
| | - George Tribonias
- Department of Gastroenterology, General Hospital of Nikea-Piraeus 'Agios Panteleimon', Athens, Greece
| | - Eirini Zacharopoulou
- Department of Gastroenterology, General Hospital of Nikea-Piraeus 'Agios Panteleimon', Athens, Greece
| | - Maria Palatianou
- Department of Gastroenterology, General Hospital of Nikea-Piraeus 'Agios Panteleimon', Athens, Greece
| | - Nikolaos Leontidis
- Department of Gastroenterology, General Hospital of Nikea-Piraeus 'Agios Panteleimon', Athens, Greece
| | - Panagiota Pantoula
- Department of Pathology, General Hospital of Nikea-Piraeus 'Agios Panteleimon', Athens, Greece
| | - Georgia Vogiatzi
- Third Department of Cardiology, Thoracic Diseases General Hospital Sotiria, National and Kapodistrian University of Athens, Athens, Greece
| | | | | | - Maria Tzouvala
- Department of Gastroenterology, General Hospital of Nikea-Piraeus 'Agios Panteleimon', Athens, Greece
| |
Collapse
|
13
|
Nezos A, Skarlis C, Psarrou A, Markakis K, Garantziotis P, Papanikolaou A, Gravani F, Voulgarelis M, Tzioufas AG, Koutsilieris M, Moutsopoulos HM, Kotsifaki E, Mavragani CP. Lipoprotein-Associated Phospholipase A2: A Novel Contributor in Sjögren's Syndrome-Related Lymphoma? Front Immunol 2021; 12:683623. [PMID: 34220834 PMCID: PMC8253309 DOI: 10.3389/fimmu.2021.683623] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/21/2021] [Accepted: 05/24/2021] [Indexed: 12/17/2022] Open
Abstract
Background B-cell non-Hodgkin’s lymphoma (B-NHL) is one of the major complications of primary Sjögren’s syndrome (SS). Chronic inflammation and macrophages in SS minor salivary glands have been previously suggested as significant predictors for lymphoma development among SS patients. Lipoprotein-associated phospholipase A2 (Lp-PLA2)—a product mainly of tissue macrophages—is found in the circulation associated with lipoproteins and has been previously involved in cardiovascular, autoimmune, and malignant diseases, including lymphoma. Objective The purpose of the current study was to investigate the contributory role of Lp-PLA2 in B-NHL development in the setting of primary SS. Methods Lp-PLA2 activity in serum samples collected from 50 primary SS patients with no lymphoma (SS-nL), 9 primary SS patients with lymphoma (SS-L), and 42 healthy controls (HC) was determined by detection of [3H]PAF degradation products by liquid scintillation counter. Moreover, additional sera from 50 SS-nL, 28 SS-L, and 32 HC were tested for Lp-PLA2 activity using a commercially available ELISA kit. Lp-PLA2 mRNA, and protein expression in minor salivary gland (MSG) tissue samples derived from SS-nL, SS-L patients, and sicca controls (SC) were analyzed by real-time PCR, Western blot, and immunohistochemistry. Results Serum Lp-PLA2 activity was significantly increased in SS-L compared to both SS-nL and HC by two independent methods implemented [mean ± SD (nmol/min/ml): 62.0 ± 13.4 vs 47.6 ± 14.4 vs 50.7 ± 16.6, p-values: 0.003 and 0.04, respectively, and 19.4 ± 4.5 vs 15.2 ± 3.3 vs 14.5 ± 3.0, p-values: <0.0001, in both comparisons]. ROC analysis revealed that the serum Lp-PLA2 activity measured either by radioimmunoassay or ELISA has the potential to distinguish between SS-L and SS-nL patients (area under the curve [AUC]: 0.8022, CI [95%]: 0.64–0.96, p-value: 0.004 for radioimmunoassay, and AUC: 0.7696, CI [95%]: 0.66–0.88, p-value: <0.0001, for ELISA). Lp-PLA2 expression in MSG tissues was also increased in SS-L compared to SS-nL and SC at both mRNA and protein level. ROC analysis revealed that both MSG mRNA and protein Lp-PLA2 have the potential to distinguish between SS-nL and SS-L patients (area under the curve [AUC] values of 0.8490, CI [95%]: 0.71–0.99, p-value: 0.0019 and 0.9444, CI [95%]: 0.79–1.00, p- value: 0.0389 respectively). No significant difference in either serum Lp-PLA2 activity or MSG tissue expression was observed between SS-nL and HC. Conclusions Lp-PLA2 serum activity and MSG tissue mRNA/protein expression could be a new biomarker and possibly a novel therapeutic target for B-cell lymphoproliferation in the setting of SS.
Collapse
Affiliation(s)
- Adrianos Nezos
- Department of Physiology, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece
| | - Charalampos Skarlis
- Department of Physiology, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece
| | - Anna Psarrou
- Department of Physiology, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece
| | - Konstantinos Markakis
- Department of Physiology, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece
| | - Panagiotis Garantziotis
- Department of Physiology, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.,Division of Immunology and Rheumatology, Hannover Medical University, Hannover, Germany
| | | | - Fotini Gravani
- Department of Rheumatology, General Hospital of Athens "G.Gennimatas", Athens, Greece
| | - Michael Voulgarelis
- Department of Pathophysiology, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece
| | - Athanasios G Tzioufas
- Department of Pathophysiology, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.,Joint Academic Rheumatology Program, National and Kapodistrian University of Athens School of Medicine, Athens, Greece
| | - Michael Koutsilieris
- Department of Physiology, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece
| | - Haralampos M Moutsopoulos
- Department of Pathophysiology, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.,Chair Medical Sciences/Immunology, Academy of Athens, Athens, Greece
| | - Eleni Kotsifaki
- Department of Physiology, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece
| | - Clio P Mavragani
- Department of Physiology, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.,Department of Pathophysiology, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.,Joint Academic Rheumatology Program, National and Kapodistrian University of Athens School of Medicine, Athens, Greece
| |
Collapse
|
14
|
Karakatsanis S, S Papadatos S, Syrigos N, Marinos L, Pouliou E, Papanikolaou A. Clinical significance of PD-1 and PD-L1 molecules in patients with diffuse large B-cell lymphoma, not otherwise specified: Correlation with clinical and pathological findings. J BUON 2021; 26:569-579. [PMID: 34077007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/12/2023]
Abstract
PURPOSE To investigate a possible chemorefractoriness mechanism of a Diffuse Large B-Cell Lymphoma (DLBCL) histological subtype, specifically of DLBCL, not otherwise specified (DLBCL, NOS), namely the effect of programmed cell death-1 (PD-1) immunoreceptor signalling, considering that the identification of additional negative prognostic factors can lead to better prognostication and therapeutic approaches. METHODS We conducted a retrospective study of DLBCL, NOS patients, gathering their clinical features and combining them with PD-1 and its ligand (PD-L1) expression at the time of diagnosis as well as their response to treatment. RESULTS No statistically significant difference was found when comparing PD-L1 positive to PD-L1 negative patients, while overall survival (OS) and duration of complete response (CR) were better for PD-L1 negative patients but the difference was not statistically significant. CONCLUSIONS PD-L1 expression was not found to have any prognostic value for our cohort of DLBCL, NOS patients. What is more, the number of PD-1 positive tumour infiltrating lymphocytes was not associated with PD-L1 expression neither on malignant nor on non-malignant cells.
Collapse
Affiliation(s)
- Stamatis Karakatsanis
- Hematology Unit, 3rd University Clinic of Internal Medicine, Sotiria General Hospital, Athens Medical School, Athens, Greece
| | | | | | | | | | | |
Collapse
|
15
|
Kastritis E, Fotiou D, Theodorakakou F, Dialoupi I, Migkou M, Roussou M, Karatrasoglou EA, Tselegkidi MI, Ntalianis A, Kanellias N, Eleutherakis-Papaiakovou E, Ntanasis-Stathopoulos I, Gakiopoulou C, Papanikolaou A, Papathoma A, Spyropoulou-Vlachou M, Psimenou E, Stamatelopoulos K, Gavriatopoulou M, Terpos E, Dimopoulos MA. Timing and impact of a deep response in the outcome of patients with systemic light chain (AL) amyloidosis. Amyloid 2021; 28:3-11. [PMID: 32713209 DOI: 10.1080/13506129.2020.1798224] [Citation(s) in RCA: 18] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
A rapid and deep haematologic response is fundamental in order to improve outcomes of patients with AL amyloidosis. We evaluated the impact of timing and depth of haematologic response at early time points (at 1 and 3 months from the start of therapy) in 227 consecutive previously untreated AL patients, who received bortezomib-based primary therapy. After 1 month of therapy, 30.5% had ≥VGPR, 28% PR and 36% no response (NR), with 11% having iFLC <20 mg/L and 15% dFLC <10 mg/L. Deep haematologic response at 1 month (either ≥VGPR or iFLC <20 mg/L or dFLC <10 mg/L), was associated with a high organ response rate. The survival of patients with ≥VGPR was significantly better than those with PR and NR at 1-month landmark (p < .001) but this benefit was mainly driven by those with iFLC <20 mg/L. The depth of haematologic response at 1 month was significant across all Mayo stages. At 3 months, 46% of the patients had not significantly improved the depth of their response but even patients that improved their response from an iFLC ≥20 mg/L at 1 month to iFLC <20 mg/L at 3 months still had inferior outcome to those with an early deep response. Thus, in patients with AL amyloidosis, a very rapid and deep response is crucial, especially for those at high risk, targeting very low FLC levels within the first month of therapy.
Collapse
Affiliation(s)
- Efstathios Kastritis
- Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece
| | - Despina Fotiou
- Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece
| | - Foteini Theodorakakou
- Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece
| | - Ioanna Dialoupi
- Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece
| | - Magdalini Migkou
- Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece
| | - Maria Roussou
- Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece
| | - Eleni A Karatrasoglou
- Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece
| | - Maria Irini Tselegkidi
- Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece
| | - Argyrios Ntalianis
- Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece
| | - Nikolaos Kanellias
- Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece
| | | | | | - Charikleia Gakiopoulou
- 1st Department of Pathology, National and Kapodistrian University of Athens, Athens, Greece
| | | | | | | | - Erasmia Psimenou
- Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece
| | - Kimon Stamatelopoulos
- Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece
| | - Maria Gavriatopoulou
- Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece
| | - Evangelos Terpos
- Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece
| | - Meletios A Dimopoulos
- Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece
| |
Collapse
|
16
|
Papanikolaou A, Barkas F, Liberopoulos E. Effect of estradiol E2 on serum PCSK9 levels and lipid profile in women undergoing in vitro fertilization. Atherosclerosis 2020. [DOI: 10.1016/j.atherosclerosis.2020.10.683] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
17
|
Soulaidopoulos S, Drakopoulou M, Stathogiannis K, Xanthopoulou M, Oikonomou G, Toskas P, Kouroutzoglou A, Synetos A, Papanikolaou A, Latsios G, Sideris S, Tousoulis D, Toutouzas K. The effect of permanent pacemaker implantation following transcatheter aortic valve implantation upon survival. Eur Heart J 2020. [DOI: 10.1093/ehjci/ehaa946.0460] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Purpose
Transcatheter aortic valve implantation (TAVI) is often followed by conduction abnormalities, leading to a permanent pacemaker implantation (PPI). Data regarding the clinical impact of PPI following TAVI is yet to be established.
Methods
Patients with severe and symptomatic aortic stenosis [effective orifice area (EOA) ≤1cm2] referred for TAVI at our institution were consecutively enrolled. Prospectively collected demographic, laboratory and echocardiographic data were retrospectively analyzed. Patients were stratified into two groups according to the need for PPI after TAVI and were followed up postoperatively with clinical and echocardiographic assessment. Primary clinical endpoint was all-cause mortality, as defined by the criteria proposed by the Valve Academic Research Consortium 2.
Results
In total, 292 patients were included (male: 50.2%, mean age: 80±7.6 years) in our study. Of these, 109 (37.5%) underwent PPI simultaneously or shortly after TAVI. The median follow-up period was 27.3 In this period, all-cause mortality showed no significant difference between patients with and those without PPI after TAVI (log-rank p=0.756), even after excluding patients with a pre-existing pacemaker from the analysis. Subgroup analysis also showed no difference in survival between patients with low ejection fraction (<50%) and those with preserved (≥50%) receiving a permanent pacemaker after TAVR (log-rank p=0.269). Taking into consideration factors that were found to associate to PPI in univariate analysis (pre TAVI - ejection fraction, pulmonary artery systolic pressure and New York Heart Association functional class) in a multivariate model, pre TAVI pulmonary artery systolic pressure was found to be an independent predictor of peri-procedural PPI [Exp(B): 0.977, 95% Confidence Interval: 0.957–0.998, B=−0.023, p=0.029]. Pre-TAVI conduction abnormalities and the degree of aortic annulus calcification, as assessed by computed-tomography, were not found to predict PPI after TAVI.
Conclusion
PPI following TAVI was not associated with survival at 27 months of follow-up, independently from the pre TAVI ejection fraction.
Figure 1
Funding Acknowledgement
Type of funding source: None
Collapse
Affiliation(s)
- S Soulaidopoulos
- Hippokration General Hospital, First Department of Cardiology, Medical School of Athens, Athens, Greece
| | - M Drakopoulou
- Hippokration General Hospital, First Department of Cardiology, Medical School of Athens, Athens, Greece
| | - K Stathogiannis
- Hippokration General Hospital, First Department of Cardiology, Medical School of Athens, Athens, Greece
| | - M Xanthopoulou
- Hippokration General Hospital, First Department of Cardiology, Medical School of Athens, Athens, Greece
| | - G Oikonomou
- Hippokration General Hospital, First Department of Cardiology, Medical School of Athens, Athens, Greece
| | - P Toskas
- Hippokration General Hospital, First Department of Cardiology, Medical School of Athens, Athens, Greece
| | - A Kouroutzoglou
- Hippokration General Hospital, First Department of Cardiology, Medical School of Athens, Athens, Greece
| | - A Synetos
- Hippokration General Hospital, First Department of Cardiology, Medical School of Athens, Athens, Greece
| | - A Papanikolaou
- Hippokration General Hospital, First Department of Cardiology, Medical School of Athens, Athens, Greece
| | - G Latsios
- Hippokration General Hospital, First Department of Cardiology, Medical School of Athens, Athens, Greece
| | - S Sideris
- Hippokration General Hospital, First Department of Cardiology, Medical School of Athens, Athens, Greece
| | - D Tousoulis
- Hippokration General Hospital, First Department of Cardiology, Medical School of Athens, Athens, Greece
| | - K Toutouzas
- Hippokration General Hospital, First Department of Cardiology, Medical School of Athens, Athens, Greece
| |
Collapse
|
18
|
Bounas P, Karanasos A, Synetos A, Papanikolaou A, Latsios G, Drakopoulou M, Trantalis G, Olympios C, Tousoulis D, Toutouzas K. Thin cap fibroatheroma and plaque rupture is associated with carotid thermal heterogeneity in patients presenting with acute myocardial infarction. Eur Heart J 2020. [DOI: 10.1093/ehjci/ehaa946.1301] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Microwave radiometry (MWR) has been applied successfully in the evaluation of carotid atherosclerosis, measuring reliably temperature heterogeneity of atherosclerotic plaques. Recent studies have shown an association between increased carotid temperature heterogeneity (ΔT) detected by MWR and cardiovascular events. Vulnerable plaques of the coronary arteries, share common characteristics such as the thin cap fibrous cap, that make the prone to rupture in the presence of stimulus such as shear stress or inflammation. Optical coherence tomography (OCT) is an imaging method, by which the fibrous cap and the presence of plaque rupture can be accurately in vivo visualized.
Purpose
To evaluate the impact of carotid temperature heterogeneity on the culprit plaque morphology on patients presenting with acute myocardial infarction.
Method
A total of 37 patients undergoing percutaneous coronary intervention (PCI) for an acute myocardial infarction who had an identifiable de novo culprit lesion in a native coronary artery, were enrolled in this study. All patients underwent PCI and Optical Coherence Study (OCT) within 12 hours since symptom onset. The OCT study was performed according to the standard techniques and acquired images were analyzed by 2 independent investigators., After the completion of the PCI all patients underwent MWR of both carotid arteries and ΔT was defined as maximal temperature detected along each carotid artery minus minimum.
Results
Thirty four patients with acute myocardial infarction 21 with STEMI (61.76%) and 13 (38.23%) with NSTEMI were included in the study. Thin cap fibroatheroma (TCFA) was present in 31 patients (91.1%), while all ruptured plaques had a TCFA compared to 11 TCFA (78.57%) observed in plaques that had no rupture (p=0.03). HsCRP was significantly increased in ruptured plaques compared to non ruptured ones (14.41±4.02 versus 9.9±2.5, p<0.005). Mean ΔT was significantly increased in ruptured plaques compared to no ruptured ones (1.01±0.31 versus 0.51±0.14°C, p<0.005), as well as in plaques with TCFA compared to those without a TCFA (0.82±0.37 versus 0.60±0.05°C, p=0.001). In the multivariate analysis DM, hsCRP, and ΔT were entered from which DM (OR 4.12; 95% CI 0.77–22.07; P=0.07) and ΔTau ((OR for 0.1°C increase 1.43; 95% CI 1.03–1.98; P=0.03) remained in the final model, with ΔT being the only variable independently associated with the presence of TCFA. Similarly regarding plaque rupture, STEMI, hsCRP, and ΔT were entered in the multivariate analysis from which hsCRP (OR 1.51; 95% CI 0.99–2.28; P=0.051) and ΔTau ((OR for 0.1°C increase 3.40; 95% CI 1.29–8.96; P=0.013) remained in the final model, with ΔT being the only variable independently associated with the presence of rupture.
Conclusions
Carotid thermal heterogeneity is associated with TCFA and plaque rupture in patients with acute myocardial infarction.
Funding Acknowledgement
Type of funding source: None
Collapse
Affiliation(s)
- P Bounas
- Thriassio General Hospital, Athens, Greece
| | - A Karanasos
- University of Athens Medical School, 1st Department of Cardiology, Athens, Greece
| | - A Synetos
- University of Athens Medical School, 1st Department of Cardiology, Athens, Greece
| | - A Papanikolaou
- University of Athens Medical School, 1st Department of Cardiology, Athens, Greece
| | - G Latsios
- University of Athens Medical School, 1st Department of Cardiology, Athens, Greece
| | - M Drakopoulou
- University of Athens Medical School, 1st Department of Cardiology, Athens, Greece
| | - G Trantalis
- University of Athens Medical School, 1st Department of Cardiology, Athens, Greece
| | - C Olympios
- Thriassio General Hospital, Athens, Greece
| | - D Tousoulis
- University of Athens Medical School, 1st Department of Cardiology, Athens, Greece
| | - K Toutouzas
- University of Athens Medical School, 1st Department of Cardiology, Athens, Greece
| |
Collapse
|
19
|
Bounas P, Synetos A, Karanasos A, Papanikolaou A, Drakopoulou M, Latsios G, Trantalis G, Olympios C, Tousoulis D, Toutouzas K. Coronary plaque rupture is associated with carotid thermal heterogeneity in patients presenting with acute myocardial infarction. Eur Heart J 2020. [DOI: 10.1093/ehjci/ehaa946.1404] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Introduction
Vulnerable plaques of the coronary arteries, share common characteristics such as the thin cap fibrous cap, that make the prone to rupture in the presence of stimulus such as shear stress or inflammation. Optical coherence tomography (OCT) is an imaging method, by which the fibrous cap and the presence of plaque rupture can be accurately in vivo visualized. Recent studies have shown an association between increased carotid temperature heterogeneity (ΔT) detected by microwave radiometry (MWR) and cardiovascular events.
Purpose
To evaluate the impact of carotid temperature heterogeneity on the culprit plaque morphology on patients presenting with acute myocardial infarction.
Method
A total of 37 patients undergoing percutaneous coronary intervention (PCI) for an acute myocardial infarction who had an identifiable de novo culprit lesion in a native coronary artery, were enrolled in this study. All patients underwent PCI and Optical Coherence Study (OCT) within 12 hours since symptom onset. The culprit lesion of the angiogram was clearly identified by a combination of ECG, wall motion abnormalities seen in cardiac ultrasound, and coronary angiogram. The OCT study was performed using the LightLab OCT wire, and acquired images were analyzed by 2 independent investigators using previously validated criteria for OCT plaque characterization. After the completion of the PCI all patients underwent MWR of both carotid arteries and ΔT was defined as maximal temperature detected along each carotid artery minus minimum.
Results
Thirty four patients with acute myocardial infarction 21 with STEMI (61.76%) and 13 (38.23%) with NSTEMI were included in the study. STEMI patients had more ruptured plaques compared to NSTEMI patients (71.41 versus 38.46%, p=0.053). Thin cap fibroatheroma (TCFA) was present in 31 patients (91.1%), while all ruptured plaques had a TCFA compared to 11 TCFA (78.57%) observed in plaques that had no rupture (p=0.03). HsCRP was significantly increased in ruptured plaques compared to non ruptured ones (14.41±4.02 versus 9.9±2,5, p<0.005). Mean ΔT was significantly increased in ruptured plaques compared to no ruptured ones (1.01±0.31 versus 0.51±0.14°C, p<0.005), as well as in plaques with TCFA compared to those without a TCFA (0.82±0.37 versus 0.60±0.05°C, p=0.001). In the multivariate analysis, STEMI, hsCRP, and ΔT were entered from which hsCRP (OR 1.51; 95% CI 0.99–2.28; P=0.051) and ΔT ((OR for 0.1°C increase 3.40; 95% CI 1.29–8.96; P=0.013) remained in the final model, with ΔT being the only variable independently associated with the presence of rupture.
Conclusions
Carotid thermal heterogeneity is associated with the presence of plaque rupture in patients with acute myocardial infarction. Further studies are needed in order to assess the possible prognostic impact of carotid ΔT on such population.
Funding Acknowledgement
Type of funding source: None
Collapse
Affiliation(s)
- P Bounas
- Thriassio General Hospital, Athens, Greece
| | - A Synetos
- University of Athens Medical School, 1st Department of Cardiology, Athens, Greece
| | - A Karanasos
- University of Athens Medical School, 1st Department of Cardiology, Athens, Greece
| | - A Papanikolaou
- University of Athens Medical School, 1st Department of Cardiology, Athens, Greece
| | - M Drakopoulou
- University of Athens Medical School, 1st Department of Cardiology, Athens, Greece
| | - G Latsios
- University of Athens Medical School, 1st Department of Cardiology, Athens, Greece
| | - G Trantalis
- University of Athens Medical School, 1st Department of Cardiology, Athens, Greece
| | - C Olympios
- Thriassio General Hospital, Athens, Greece
| | - D Tousoulis
- University of Athens Medical School, 1st Department of Cardiology, Athens, Greece
| | - K Toutouzas
- University of Athens Medical School, 1st Department of Cardiology, Athens, Greece
| |
Collapse
|
20
|
Drakopoulou M, Soulaidopoulos S, Stathogiannis K, Oikonomou G, Toskas P, Kouroutzoglou A, Papanikolaou A, Synetos A, Latsios G, Sideris S, Tousoulis D, Toutouzas K. Prognostic implication of electrocardiographic left ventricular strain in patients undergoing Transcatheter Aortic Valve Implantation. Eur Heart J 2020. [DOI: 10.1093/ehjci/ehaa946.0375] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Electrocardiographic (ECG) strain has been linked to excess cardiovascular morbidity and mortality in asymptomatic patients with aortic stenosis.
Purpose
We aim to determine the differential impact of baseline ECG-strain on long-term mortality after transcatheter aortic valve implantation (TAVI).
Methods
Patients with severe and symptomatic aortic stenosis (effective orifice area [EOA]≤1cm2), who were scheduled for TAVI with a self-expanding valve between May 2015 and May 2018 were consecutively enrolled. Left ventricular strain was defined as the presence of ≥1mm convex ST-segment depression with asymmetrical T-wave inversion in leads V5 to V6 on baseline ECG. Patients were excluded, if they had bundle branch block or a permanent pacemaker at baseline. Baseline parameters were compared, and multivariate Cox proportional hazard regression models were generated to assess outcome difference. The primary clinical endpoint was cumulative mortality defined according to the criteria proposed by the Valve Academic Research Consortium-2.
Results
Of the 171 patients screened, 56 patients were excluded due to left bundle branch block or paced rhythm. In the 115 included patients (mean age: 81.4±7), 36 patients (31.3%) had strain pattern on pre-TAVI ECG. There were no differences in baseline characteristics between the two groups. During a median follow-up of 2.32 years (IQR 1.62 to 3), 11 patients (9.6%) reached the primary clinical endpoint. Patients in the strain group had higher incidence of all-cause mortality compared to patients without left ventricular strain (25% vs 2.5%, χ2=14.4, p<0.001). Kaplan-Meier survival analysis showed a significantly decreased cumulative probability of survival at 3 years in patients with LV-strain compared with patients without LV-strain (log-rank p=0.002, Figure 1). In the multivariate analysis, left ventricular strain [Exp(B): 8.952, 95% Confidence Interval (CI): 1.215–65.938, B=2.192, p=0.031] and QRS duration [Exp(B): 1.058, 95% CI: 1.022–1.095, B=0.056, p<0.001] were found to be independent predictors of all-cause mortality after TAVI.
Conclusion
Baseline ECG left ventricular strain was an independent predictor of long-term mortality post TAVI. Systematic strain measurements might aid in risk-stratifying patients scheduled for TAVI.
Figure 1
Funding Acknowledgement
Type of funding source: None
Collapse
Affiliation(s)
- M Drakopoulou
- Hippokration General Hospital, First Department of Cardiology, Medical School of Athens, Athens, Greece
| | - S Soulaidopoulos
- Hippokration General Hospital, First Department of Cardiology, Medical School of Athens, Athens, Greece
| | - K Stathogiannis
- Hippokration General Hospital, First Department of Cardiology, Medical School of Athens, Athens, Greece
| | - G Oikonomou
- Hippokration General Hospital, First Department of Cardiology, Medical School of Athens, Athens, Greece
| | - P Toskas
- Hippokration General Hospital, First Department of Cardiology, Medical School of Athens, Athens, Greece
| | - A Kouroutzoglou
- Hippokration General Hospital, First Department of Cardiology, Medical School of Athens, Athens, Greece
| | - A Papanikolaou
- Hippokration General Hospital, First Department of Cardiology, Medical School of Athens, Athens, Greece
| | - A Synetos
- Hippokration General Hospital, First Department of Cardiology, Medical School of Athens, Athens, Greece
| | - G Latsios
- Hippokration General Hospital, First Department of Cardiology, Medical School of Athens, Athens, Greece
| | - S Sideris
- Hippokration General Hospital, First Department of Cardiology, Medical School of Athens, Athens, Greece
| | - D Tousoulis
- Hippokration General Hospital, First Department of Cardiology, Medical School of Athens, Athens, Greece
| | - K Toutouzas
- Hippokration General Hospital, First Department of Cardiology, Medical School of Athens, Athens, Greece
| |
Collapse
|
21
|
Paschali A, Panagiotidis E, Triantafyllou T, Palaska V, Tsirou K, Verrou E, Υiannaki E, Markala D, Papanikolaou A, Pouli A, Konstantinidou P, Chatzipavlidou V, Terpos E, Katodritou E. A proposed index of diffuse bone marrow [18F]-FDG uptake and PET skeletal patterns correlate with myeloma prognostic markers, plasma cell morphology, and response to therapy. Eur J Nucl Med Mol Imaging 2020; 48:1487-1497. [PMID: 33099659 DOI: 10.1007/s00259-020-05078-1] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/10/2020] [Accepted: 10/15/2020] [Indexed: 11/26/2022]
Abstract
PURPOSE The investigation of a semi-quantitative index in the pelvis to assess for diffuse bone marrow (BM) [18F]-FDG uptake and the investigation of PET skeletal patterns in multiple myeloma (MM) patients, in accordance with prognostic markers, clonal plasma cell (cPC) morphology, and response to therapy. METHODS We prospectively analyzed [18F]-FDG PET/CT in 90 MM patients (newly diagnosed, 60; relapsed/refractory, 30). Among other PET/CT parameters, we calculated the ratio SUVmax pelvis/liver and examined for correlations with known MM prognostic parameters, cPC morphology (good vs. low/intermediate differentiation), and response to therapy. RESULTS SUVmax pelvis/liver ratio was significantly lower for the group of good differentiation vs. intermediate/low differentiation cPCs (p < 0.001) and showed a positive correlation with BM infiltration rate, β2 microglobulin, serum ferritin, international staging system (ISS), and revised ISS; no significant correlation was found with hemoglobin. A cutoff value of 1.1 showed an excellent specificity (99%) and high sensitivity (76%) for diffuse BM involvement (AUC 0.94; p < 0.001). Mixed pattern and appendicular involvement correlated with poor prognostic features while normal pattern, found in 30% of patients, correlated with good prognostic features. Presence of ≥ 10 focal lesions negatively predicted for overall response (p < 0.05; OR 4.8). The CT component improved the diagnostic performance of PET. CONCLUSION This study showed, for the first time, that cPC morphology and markers related with MM biology, correlate with SUVmax pelvis/liver index, which could be used as a surrogate marker for BM assessment and disease prognosis; PET patterns correlate with MM prognostic features and response rates.
Collapse
Affiliation(s)
- A Paschali
- Department of Nuclear Medicine, Theagenion Cancer Hospital, Thessaloniki, Greece.
| | - E Panagiotidis
- Department of Nuclear Medicine, Theagenion Cancer Hospital, Thessaloniki, Greece
| | - T Triantafyllou
- Department of Hematology, Theagenion Cancer Hospital, Thessaloniki, Greece
| | - V Palaska
- Department of Hematology, Theagenion Cancer Hospital, Thessaloniki, Greece
| | - K Tsirou
- Department of Hematology, Theagenion Cancer Hospital, Thessaloniki, Greece
| | - E Verrou
- Department of Hematology, Theagenion Cancer Hospital, Thessaloniki, Greece
| | - E Υiannaki
- Hematology/Flow cytometry Lab, Theagenion Cancer Hospital, Thessaloniki, Greece
| | - D Markala
- Hematology/Flow cytometry Lab, Theagenion Cancer Hospital, Thessaloniki, Greece
| | - A Papanikolaou
- Hematopathology Department, Evangelismos General Hospital, Athens, Greece
| | - A Pouli
- Hematology Department, "St Savvas" Oncology Hospital, Athens, Greece
| | - P Konstantinidou
- Department of Hematology, Theagenion Cancer Hospital, Thessaloniki, Greece
| | - V Chatzipavlidou
- Department of Nuclear Medicine, Theagenion Cancer Hospital, Thessaloniki, Greece
| | - E Terpos
- Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
| | - E Katodritou
- Department of Hematology, Theagenion Cancer Hospital, Thessaloniki, Greece
| |
Collapse
|
22
|
Papaioannou TG, Georgiopoulos G, Stamatelopoulos KS, Protogerou AD, Alexandraki KI, Argyris A, Vrachatis DA, Soulis D, Papanikolaou A, Manolesou D, Daskalopoulou SS, Tousoulis D. Blood pressure variability within a single visit and all-cause mortality. Neth J Med 2020; 78:175-182. [PMID: 32641542] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/11/2023]
Abstract
BACKGROUND Within-visit variability of repeated sequential readings of blood pressure (BP) is an important phenomenon that may affect precision of BP measurement and thus decision making concerning BP-related risk and hypertension management. However, limited data exist concerning predictive ability of within-visit BP variability for clinical outcomes. Therefore, we aimed to investigate the association between the variability of three repeated office BP measurements and the risk of all-cause mortality, independent of BP levels. METHODS Data collected through the National Health and Nutrition Examination Survey (NHANES) were analysed. NHANES is a program of studies designed to assess health and nutritional status of adults and children in the United States. A complete set of three sequential BP measurements, together with survival status, were available for 24969 individuals (age 46.8±;19.3 years, 49% males). Multivariable logistic regression models were used to determine the prognostic ability of the examined demographic, clinical, and haemodynamic indices. RESULTS Among various examined indices of variability of systolic (SBP) and diastolic (DBP) blood pressure measurements, the standard deviation of DBP (DBPSD) was the stronger independent predictor of mortality (odds ratio 1.064, 95% Confidence Interval: 1.011-1.12) after adjustment for age, sex, body mass index, smoking, SBP, heart rate, history of hypertension, diabetes mellitus, hypercholesterolaemia, and cardiovascular events. CONCLUSION Within-visit variability of three sequential office DBP readings may allow for the identification of high-risk patients better than mean SBP and DBP levels. The predictive value of within-visit BP variability and methods to improve its clinical application are worthy of further research.
Collapse
Affiliation(s)
- T G Papaioannou
- First Department of Cardiology, Biomedical Engineering Unit, Hippokration Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
23
|
Boklund A, Dhollander S, Chesnoiu Vasile T, Abrahantes JC, Bøtner A, Gogin A, Gonzalez Villeta LC, Gortázar C, More SJ, Papanikolaou A, Roberts H, Stegeman A, Ståhl K, Thulke HH, Viltrop A, Van der Stede Y, Mortensen S. Risk factors for African swine fever incursion in Romanian domestic farms during 2019. Sci Rep 2020; 10:10215. [PMID: 32576841 PMCID: PMC7311386 DOI: 10.1038/s41598-020-66381-3] [Citation(s) in RCA: 62] [Impact Index Per Article: 15.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/24/2020] [Accepted: 05/18/2020] [Indexed: 01/06/2023] Open
Abstract
African swine fever (ASF) entered Georgia in 2007 and the EU in 2014. In the EU, the virus primarily spread in wild boar (Sus scrofa) in the period from 2014-2018. However, from the summer 2018, numerous domestic pig farms in Romania were affected by ASF. In contrast to the existing knowledge on ASF transmission routes, the understanding of risk factors and the importance of different transmission routes is still limited. In the period from May to September 2019, 655 Romanian pig farms were included in a matched case-control study investigating possible risk factors for ASF incursion in commercial and backyard pig farms. The results showed that close proximity to outbreaks in domestic farms was a risk factor in commercial as well as backyard farms. Furthermore, in backyard farms, herd size, wild boar abundance around the farm, number of domestic outbreaks within 2 km around farms, short distance to wild boar cases and visits of professionals working on farms were statistically significant risk factors. Additionally, growing crops around the farm, which could potentially attract wild boar, and feeding forage from ASF affected areas to the pigs were risk factors for ASF incursion in backyard farms.
Collapse
Affiliation(s)
- A Boklund
- University of Copenhagen, Faculty of Health and Medical Sciences, Section for Animal Welfare and Disease Control, Grønnegårdsvej 8, 1870, Frederiksberg C, Denmark.
| | - S Dhollander
- European Food Safety Authority, Via Carlo Magno 1A, 43126, Parma, Italy
| | - T Chesnoiu Vasile
- The National Sanitary Veterinary and Food Safety Authority, Bucharest, Piata Free Press no. 1 Body D1, District 1, Post Code 013 701, Bucharest, Romania
| | - J C Abrahantes
- European Food Safety Authority, Via Carlo Magno 1A, 43126, Parma, Italy
| | - A Bøtner
- University of Copenhagen, Faculty of Health and Medical Sciences, Section for Veterinary Clinical Microbiology, Stigbøjlen 4, 1870, Frederiksberg C, Denmark
- Statens Serum Institut, Department of Virus and Microbiological Special Diagnostics, Artillerivej 5, 2300, Copenhagen S, Denmark
| | - A Gogin
- Federal Research Center for Virology and Microbiology, 601125, Volginsky, Russia
| | | | - C Gortázar
- SaBio research group at IREC (Universidad de Castilla-La Mancha & CSIC), Ronda de Toledo 12, 13003, Ciudad Real, Spain
| | - S J More
- Centre for Veterinary Epidemiology and Risk Analysis, UCD School of Veterinary Medicine, University College Dublin, Belfield, Dublin, D04 W6F6, Ireland
| | - A Papanikolaou
- European Food Safety Authority, Via Carlo Magno 1A, 43126, Parma, Italy
| | - H Roberts
- Department for Environment Food and Rural Affairs (DEFRA), Exotic Disease Control team, Area 2D, Nobel House, 17 Smith Square, London, SW1P 3JR, England
| | - A Stegeman
- Utrecht University, Faculty of Veterinary Medicine, Yalelaan 7, Utrecht, The Netherlands
| | - K Ståhl
- National Veterinary Institute, 751 89, Uppsala, Sweden
| | - H H Thulke
- Helmholtz Centre for Environmental Research GmbH - UFZ, Department of Ecological Modelling, PG EcoEpi, Permoserstr. 15, Leipzig, Germany
| | - A Viltrop
- Estonian University of Life Sciences, Institute of Veterinary Medicine and Animal Sciences, Kreutzwaldi 62, Tartu, 51006, Estonia
| | - Y Van der Stede
- European Food Safety Authority, Via Carlo Magno 1A, 43126, Parma, Italy
| | - S Mortensen
- Danish Veterinary and Food Administration, Stationsparken 31-33, 2600, Glostrup, Denmark
| |
Collapse
|
24
|
Papageorgiou S, Katsikas T, Voukelatou P, Vrettos I, Papanikolaou A, Bouchla A, Pappa V, Kalliakmanis A. Multiple osteolytic lesions due to Double-Expressor Primary non-Hodgkin Lymphoma of the Bone. Autops Case Rep 2020; 10:e2020141. [PMID: 33344270 PMCID: PMC7703350 DOI: 10.4322/acr.2020.141] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
Abstract
Primary non-Hodgkin lymphoma of the bone (PLB) is a rare type of non-Hodgkin’s lymphoma (NHL) that affects the skeletal system with or without regional lymph node involvement. We present the case of a 74-year-old female patient with pain due to multifocal osteolytic lesions. The diagnosis of diffuse large B-cells (non-GCB) phenotype was made by clinical, laboratory, histopathological examination accompanied by an extensive immunohistochemical profile of one of the skeletal lesions.
Collapse
Affiliation(s)
- Sotirios Papageorgiou
- University General Hospital "Attikon", Second Department of Internal Medicine, Propaedeutic and Research Unit. Haidari, Greece
| | - Theodoros Katsikas
- General and Oncology Hospital of Kifissia "Agioi Anargyroi", Second Department of Internal Medicine. Athens, Greece
| | - Panagiota Voukelatou
- General and Oncology Hospital of Kifissia "Agioi Anargyroi", Second Department of Internal Medicine. Athens, Greece
| | - Ioannis Vrettos
- General and Oncology Hospital of Kifissia "Agioi Anargyroi", Second Department of Internal Medicine. Athens, Greece
| | | | - Anthi Bouchla
- University General Hospital "Attikon", Second Department of Internal Medicine, Propaedeutic and Research Unit. Haidari, Greece
| | - Vasiliki Pappa
- University General Hospital "Attikon", Second Department of Internal Medicine, Propaedeutic and Research Unit. Haidari, Greece
| | - Andreas Kalliakmanis
- General and Oncology Hospital of Kifissia "Agioi Anargyroi", Second Department of Internal Medicine. Athens, Greece
| |
Collapse
|
25
|
Angelis A, Chrysohoou C, Laina A, Antoniou CK, Konstantinou K, Aznaourides K, Georgakopoulos C, Papanikolaou A, Dilaveris P, Vlachopoulos C, Tousoulis D. P4534The Mediterranean diet benefit in chronic heart failure by decoding central and peripheral vessel rheology, atheroma formation and serum prolactin levels. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz745.0926] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Central hemodynamics and especially wave reflection amplification exhibit a vital parameter of chronic heart failure (CHF) physiology. Erectile dysfunction (ED) displays a poor peripheral vessel rheology and serum prolactin role is still debated in CHF mechanisms. The Mediterranean diet (Med-diet) is famous for its vasoprotective and wellbeing properties.
Purpose
To investigate the effect of the Med-diet in central hemodynamics, erectile status, atheroma formation and serum prolactin levels in male patients with chronic heart failure.
Methods
123 CHF male patients under optimal medical therapy enrolled the study (mean age: 65±8 yo, NYHA class II, ejection fraction <40%). All underwent evaluation of the carotid – femoral pulse wave velocity (PWV), estimation of central pressures and augmentation index (AIx) as parameter of wave reflection amplification (sphygmocor device). Ejection fraction (EF) of the left ventricle was estimated by using 2D echocardiography (Simpson method). ED severity and adherence to the Med-diet were assessed by the SHIM-5 (range: 0–25) and the Med-diet (range: 0–55) scores. Higher values point to better erectile function and a great Med-diet compliance respectively. Detection of atheroma was based on the intima- media thickness (IMT) of the common carotid artery. Prolactin levels were assessed in morning blood samples taken before 09:00 am.
Results
The SHIM −5 score (mean: 12±4) was associated to the AIx (p=0,03, r=0,75) and both positively and strongly related to the Med-diet score (p=0,01, r=0,8 and p=0,01, r=0,75 respectively). Med-diet compliance was negatively associated to IMT (p=0,02, r=−0,8) and serum prolactin levels (p=0,03, r=−0,6).Moreover, we notice a positive association between prolactin and the IMT (p=0,04, r=0,7). By multiple linear regression analysis the relation of SHIM-5 and Med-diet score remained significant (p=0,04) after adjustment for BMI, central pulse and mean arterial pressures. We further subdivide our population according to the mean Med-diet value (28) into high and low Med-diet adherence groups. Only in the group with the greater Med-diet adherence (n=73, 60%) AIx was strongly associated to the SHIM-5 score (p=0,02) even after adjustment for PWV, age and BMI. Prolactin levels there were still related to IMT (p=0,04) after adjustment for PWV, AIx, BMI and central pulse pressure. All statistics remained significant when adjusting for ejection fraction of the left ventricle.
Conclusion
High adherence to the Med-diet benefits CHF hemodynamics by enforcing wave reflection amplification, thus generating a stronger pulse signal to peripheral vasculature. Moreover suppresses serum prolactin levels that relates to atheroma formation. Both actions enhance erectile performance independently of the EF of the left ventricle. It is important to advise CHF patients to adopt this dietary pattern in order to improve hemodynamic status and the sense of wellbeing.
Collapse
Affiliation(s)
- A Angelis
- Hippokration Hospital, University of Athens, 1st Department of Cardiology, Athens, Greece
| | - C Chrysohoou
- Hippokration Hospital, University of Athens, 1st Department of Cardiology, Athens, Greece
| | - A Laina
- Hippokration Hospital, University of Athens, 1st Department of Cardiology, Athens, Greece
| | - C.-K Antoniou
- Hippokration Hospital, University of Athens, 1st Department of Cardiology, Athens, Greece
| | - K Konstantinou
- Hippokration Hospital, University of Athens, 1st Department of Cardiology, Athens, Greece
| | - K Aznaourides
- Hippokration Hospital, University of Athens, 1st Department of Cardiology, Athens, Greece
| | - C Georgakopoulos
- Hippokration Hospital, University of Athens, 1st Department of Cardiology, Athens, Greece
| | - A Papanikolaou
- Hippokration Hospital, University of Athens, 1st Department of Cardiology, Athens, Greece
| | - P Dilaveris
- Hippokration Hospital, University of Athens, 1st Department of Cardiology, Athens, Greece
| | - C Vlachopoulos
- Hippokration Hospital, University of Athens, 1st Department of Cardiology, Athens, Greece
| | - D Tousoulis
- Hippokration Hospital, University of Athens, 1st Department of Cardiology, Athens, Greece
| |
Collapse
|
26
|
Foukas P, Koliou GA, Papoudou-Bai A, Charchanti A, Vrettou E, Poulios C, Chatzopoulos K, Kotoula V, Fountzilas E, Zakopoulou R, Visvikis A, Pentheroudakis G, Pectasides D, Aravantinos G, Oikonomopoulos G, Papanikolaou A, Haidopoulos D, Zagouri F, Fountzilas G, Goussia A. Prognostic significance of elements of the adaptive immunity in the microenvironment of epithelial ovarian cancer. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz250.027] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
27
|
Kastritis E, Karatrasoglou E, Dialoupi I, Gavriatopoulou M, Roussou M, Fotiou D, Kanellias N, Ntanasis-Stathopoulos I, Eleutherakis-Papaiakovou E, Manios E, Migkou M, Papanota AM, Papadopoulou E, Stamatelopoulos K, Ntalianis A, Papanikolaou A, Psimenou E, Gakiopoulou C, Tsitsilonis O, Tselegkidi M, Trougakos I, Kostopoulos I, Terpos E, Dimopoulos M. PS1378 AN EARLY, WITHIN THE FIRST MONTH, AND DEEP RESPONSE, SHOULD BE THE GOAL OF THERAPY IN AL AMYLOIDOSIS. Hemasphere 2019. [DOI: 10.1097/01.hs9.0000563788.88142.a3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
28
|
Kakavas S, Karayiannis D, Papanikolaou A, Karachaliou A, Mastora Z, Pavlara M, Boulbasakos G. Food group consumption and lung function parameters among hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease. Clin Nutr 2018. [DOI: 10.1016/j.clnu.2018.06.1340] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
29
|
Panahi M, Papanikolaou A, Khan H, Torabi A, Cleland JGF, Vadgama N, Rosenthal NA, Harding S, Sattler S. P2861A systematic review and meta-analysis of anti-cytokine therapies targeting IL-1 and TNF- A in myocardial infarction and heart failure. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy565.p2861] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- M Panahi
- Imperial College London, National Heart and Lung Instutute, Hammersmith Hospital, London, United Kingdom
| | - A Papanikolaou
- Imperial College London, National Heart and Lung Instutute, Hammersmith Hospital, London, United Kingdom
| | - H Khan
- Imperial College Healthcare NHS Trust, London, United Kingdom
| | - A Torabi
- Imperial College Healthcare NHS Trust, London, United Kingdom
| | - J G F Cleland
- Imperial College Healthcare NHS Trust, London, United Kingdom
| | - N Vadgama
- Imperial College London, National Heart and Lung Instutute, Hammersmith Hospital, London, United Kingdom
| | - N A Rosenthal
- The Jackson Laboratory, Bar Harbor, Maine, United States of America
| | - S Harding
- Imperial College London, National Heart and Lung Instutute, Hammersmith Hospital, London, United Kingdom
| | - S Sattler
- Imperial College London, National Heart and Lung Instutute, Hammersmith Hospital, London, United Kingdom
| |
Collapse
|
30
|
Stathogiannis K, Toutouzas K, Drakopoulou M, Latsios G, Synetos A, Oikonomou G, Xanthopoulou M, Trantalis G, Papanikolaou A, Peskesis G, Tsiamis E, Tousoulis D. 5250Effect of aortic valve calcification as measured by computed tomography in patients undergoing transcatheter aortic valve implantation. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy566.5250] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Affiliation(s)
- K Stathogiannis
- Hippokration Hospital, University of Athens, 1st Department of Cardiology, Athens, Greece
| | - K Toutouzas
- Hippokration Hospital, University of Athens, 1st Department of Cardiology, Athens, Greece
| | - M Drakopoulou
- Hippokration Hospital, University of Athens, 1st Department of Cardiology, Athens, Greece
| | - G Latsios
- Hippokration Hospital, University of Athens, 1st Department of Cardiology, Athens, Greece
| | - A Synetos
- Hippokration Hospital, University of Athens, 1st Department of Cardiology, Athens, Greece
| | - G Oikonomou
- Hippokration Hospital, University of Athens, 1st Department of Cardiology, Athens, Greece
| | - M Xanthopoulou
- Hippokration Hospital, University of Athens, 1st Department of Cardiology, Athens, Greece
| | - G Trantalis
- Hippokration Hospital, University of Athens, 1st Department of Cardiology, Athens, Greece
| | - A Papanikolaou
- Hippokration Hospital, University of Athens, 1st Department of Cardiology, Athens, Greece
| | - G Peskesis
- Hippokration Hospital, University of Athens, 1st Department of Cardiology, Athens, Greece
| | - E Tsiamis
- Hippokration Hospital, University of Athens, 1st Department of Cardiology, Athens, Greece
| | - D Tousoulis
- Hippokration Hospital, University of Athens, 1st Department of Cardiology, Athens, Greece
| |
Collapse
|
31
|
Drakopoulou M, Toutouzas K, Stathogiannis K, Latsios G, Synetos A, Sideris S, Trantalis G, Papanikolaou A, Oikonomou G, Xanthopoulou M, Karmpalioti M, Tsiamis E, Tousoulis D. P6306Impact of aorto-ventricular angulation on clinical outcomes following TAVR with a self-expanding valve. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy566.p6306] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- M Drakopoulou
- Hippokration Hospital, University of Athens, 1st Department of Cardiology, Athens, Greece
| | - K Toutouzas
- Hippokration Hospital, University of Athens, 1st Department of Cardiology, Athens, Greece
| | - K Stathogiannis
- Hippokration Hospital, University of Athens, 1st Department of Cardiology, Athens, Greece
| | - G Latsios
- Hippokration Hospital, University of Athens, 1st Department of Cardiology, Athens, Greece
| | - A Synetos
- Hippokration Hospital, University of Athens, 1st Department of Cardiology, Athens, Greece
| | - S Sideris
- Hippokration Hospital, University of Athens, 1st Department of Cardiology, Athens, Greece
| | - G Trantalis
- Hippokration Hospital, University of Athens, 1st Department of Cardiology, Athens, Greece
| | - A Papanikolaou
- Hippokration Hospital, University of Athens, 1st Department of Cardiology, Athens, Greece
| | - G Oikonomou
- Hippokration Hospital, University of Athens, 1st Department of Cardiology, Athens, Greece
| | - M Xanthopoulou
- Hippokration Hospital, University of Athens, 1st Department of Cardiology, Athens, Greece
| | - M Karmpalioti
- Hippokration Hospital, University of Athens, 1st Department of Cardiology, Athens, Greece
| | - E Tsiamis
- Hippokration Hospital, University of Athens, 1st Department of Cardiology, Athens, Greece
| | - D Tousoulis
- Hippokration Hospital, University of Athens, 1st Department of Cardiology, Athens, Greece
| |
Collapse
|
32
|
Balfousias T, Apostolopoulos AP, Papanikolaou A, Karadimas E, Zouboulis G, Maris I. Scapulothoracic Dissociation and Clavicle Fracture with Associated Brachial Plexus Palsy. J Long Term Eff Med Implants 2018; 28:233-237. [DOI: 10.1615/jlongtermeffmedimplants.2018029212] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/11/2023]
|
33
|
Papakonstantinou N, Zisis C, Balis E, Papanikolaou A, Bouros D. P-186H-TYPE TRACHEO-OESOPHAGEAL FISTULA: A CONGENITAL DEFORMITY FIRST DIAGNOSED 59 YEARS POSTNATALLY. Interact Cardiovasc Thorac Surg 2017. [DOI: 10.1093/icvts/ivx280.186] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
34
|
Kakavas S, Karayiannis D, Papanikolaou A, Baschali A, Sarantidou M, Karachaliou A, Karli A, Mastora Z, Palavra M, Boulbasakos G. SUN-P126: Bioelectrical Impedance Analysis Phase Angle as a Prognostic Marker for Outcome in Patients Admitted in Hospital with Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Clin Nutr 2017. [DOI: 10.1016/s0261-5614(17)30501-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
35
|
Synetos A, Papanikolaou A, Georgiopoulos G, Peskesis G, Drakopoulou M, Galanakos S, Benetos G, Stathogiannis K, Karanasos A, Toutouzas K, Tousoulis D. P4402Metabolic syndrome predicts plaque rupture in patients with acute myocardial Infarction. An optical coherence study. Eur Heart J 2017. [DOI: 10.1093/eurheartj/ehx504.p4402] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
36
|
Antonopoulos A, Oikonomou E, Tsalamandris S, Vogiatzi G, Tolis P, Papanikolaou A, Kalogeras K, Latsios G, Syrseloudis D, Aznaouridis K, Vaina S, Siasos G, Vavouranakis E, Toutouzas K, Tousoulis D. P4286Endothelial function post radial artery catheterization: a systematic review and meta-analysis. Eur Heart J 2017. [DOI: 10.1093/eurheartj/ehx504.p4286] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
37
|
Synetos A, Georgiopoulos G, Pylarinou V, Peskesis G, Papanikolaou A, Karanasos A, Stathogiannis K, Galanakos S, Benetos G, Tsiamis E, Toutouzas K, Drakopoulou M, Tousoulis D. P2484EuroSCORE II has the best predictive ability after successful primary percutaneous coronary intervention for the treatment of acute myocardial infarction. Eur Heart J 2017. [DOI: 10.1093/eurheartj/ehx502.p2484] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
38
|
Synetos A, Papanikolaou A, Georgiopoulos G, Peskesis G, Drakopoulou M, Galanakos S, Karanasos A, Stathogiannis K, Koutajiar I, Toutouzas K, Tousoulis D. P3662CRP predicts cap thickness in the culprit lesions of patients with metabolic syndrome and acute myocardial infarction. An Optical Coherence Study. Eur Heart J 2017. [DOI: 10.1093/eurheartj/ehx504.p3662] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
39
|
Synetos A, Toutouzas K, Drakopoulou M, Koutajiar I, Stathogiannis K, Peskesis G, Papanikolaou A, Kotronias R, Agrogiannis G, Papalois A, Anagnostopoulos C, Cokkinos D, Patsouris E, Tousoulis D. P1565Attenuation of aortic valve calcification by local delivery of zoledronic acid. A PET/CT study. Eur Heart J 2017. [DOI: 10.1093/eurheartj/ehx502.p1565] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
40
|
Bilalis A, Pouliou E, Roussou M, Papanikolaou A, Tassidou A, Economopoulos T, Terpos E. Increased expression of platelet derived growth factor receptor β on trephine biopsies correlates with advanced myeloma. J BUON 2017; 22:1032-1037. [PMID: 28952224] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/07/2023]
Abstract
PURPOSE Multiple myeloma (MM), a major cause of cancer mortality, is considered the second most frequent haematological malignancy in Europe. Angiogenesis is a multifactorial process that drives the tumorigenesis in solid tumors and in MM. The platelet derived growth factor (PDGF) receptors are cell surface tyrosine kinase receptors and play an important role in angiogenesis, cancer cell proliferation and dissemination. Few studies have been conducted regarding the expression of PDGF receptors and the correlation with clinical-pathological parameters and prognosis in MM. The purpose of our study was to evaluate, for the first time, in a large cohort of newly-diagnosed MM (NDMM) patients, the expression of PDGF receptor α and β (PDGFR α, β) in bone marrow trephine biopsies and investigate the association of PDGFR α, PDGFR β with angiogenesis in the bone marrow, assessed by bone marrow microvessel density (MVD), clinical characteristics and prognosis. METHODS In this retrospective study, we assessed the relation of PDGFR α and PDGFR β immunohistochemical expression with MVD in formalin-fixed paraffin-embedded bone marrow sections from 120 NDMM patients. The immunoreactivity of PDGFR α and β was examined on the basis of positive plasma cells (PCs) with specific cut off values. RESULTS PDGFRα and PDGFRβ were frequently expressed on malignant PCs. We found that increased PDGFRβ expression was strongly associated with advanced disease and adverse prognosis. The expression of PDGFRα and MDV were not correlated with specific features. CONCLUSION This analysis showed highly expressed PDGFRα and β PCs of NDMM patients and indicated that high PDGFRβ expression at diagnosis was associated with advanced-stage disease.
Collapse
Affiliation(s)
- Antonios Bilalis
- Second Department of Internal Medicine-Propaedeutic, Athens University Medical School, Attikon University Hospital, Athens, Greece
| | | | | | | | | | | | | |
Collapse
|
41
|
Klonos E, Zepiridis L, Theodoridis T, Tsolakidis D, Grimbizis G, Papanikolaou A, Tarlatzis B. Endometrial stromal nodule in a woman with abnormal uterine bleeding and abdominal pain: a case report. Eur J Obstet Gynecol Reprod Biol 2016. [DOI: 10.1016/j.ejogrb.2016.07.176] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
42
|
Kotoula V, Lakis S, Giannoulatou E, Kouvatseas G, Lazaridis G, Tikas I, Efstratiou I, Chrisafi S, Charalambous E, Papanikolaou A, Fostira F, Tarlatzis B, Fountzilas G. Impact of genomic heterogeneity and mutation patterns on the outcome of patients with epithelial ovarian cancer (EOC). Ann Oncol 2016. [DOI: 10.1093/annonc/mdw374.22] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
43
|
Pestell RG, Casimiro MC, Crosariol M, Loro E, Dampier W, Di Sante G, Ertel A, Yu Z, Saria EA, Papanikolaou A, Li Z, Wang C, Addya S, Lisanti MP, Fortina P, Tozeren A, Knudsen ES, Arnold A. Abstract P5-07-06: Kinase-independent role of cyclin D1 in chromosomal instability and mammary tumorigenesis. Cancer Res 2013. [DOI: 10.1158/0008-5472.sabcs13-p5-07-06] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Cyclin D1 is an important molecular driver of human breast cancer but better understanding of its oncogenic mechanisms is needed, especially to enhance efforts in targeted therapeutics. Activation of the cyclin D1 oncogene, often by amplification or rearrangement, is a major driver of multiple types of human tumors including breast and squamous cell cancers, B-cell lymphoma, myeloma, and parathyroid adenoma. The cyclin D1 gene is amplified or overexpressed in up to half of human breast cancers and its mammary-targeted overexpression induces mammary tumorigenesis in mice. Cyclin D1 encodes the regulatory subunit of the cyclin-dependent kinase (CDK) holoenzyme that phosphorylates several substrates including the retinoblastoma protein (pRb) to advance the G1S cell cycle checkpoint, promote DNA synthesis and regulate NRF-1 to inhibit mitochondrial biogenesis thereby coordinating nuclear and mitochondrial functions.
In addition to cyclin D1's function as a regulatory subunit of a CDK holoenzyme, several CDK-independent functions have been identified. Tumors overexpressing cyclin D1 tend to display normal levels of proliferation and expression of E2F target genes, which contrasts with tumors overexpressing cyclin E or an activator for pRb. Breast cancers overexpressing cyclin D1 that are wild type for pRb have relatively normal proliferation rates, in contrast to those caused by genetic inactivation of pRb, which show significantly increased proliferation rates. Furthermore, the alternate splice form of cyclin D1, (cyclin D1b), has potent transforming ability, which does not correlate with the ability to phosphorylate the pRb protein. Several other properties of cyclin D1 have been identified including the induction of cellular migration and enhanced angiogenesis, inhibition of mitochondrial biogenesis, and mediating DNA-damage repair signaling. Cyclin D1 binding proteins participating in these putatively CDK-independent functions include PACSIN2, NRF1, and p27KIP1; binding to p27KIP1 and PACSIN2 contribute to the pro-migratory function of cyclin D1.
Currently, pharmaceutical initiatives to inhibit cyclin D1 are focused on the catalytic component since the transforming capacity is thought to reside in the cyclin D1/CDK activity. We initiated the following study to directly test the oncogenic potential of catalytically inactive cyclin D1 in an in vivo mouse model that is relevant to breast cancer. Herein, transduction of cyclin D1-/- mouse embryonic fibroblasts (MEFs) with the kinase dead KE mutant of cyclin D1 led to aneuploidy, abnormalities in mitotic spindle formation, autosome amplification, and chromosomal instability (CIN) by gene expression profiling. Acute transgenic expression of either cyclin D1WT or cyclin D1KE in the mammary gland was sufficient to induce the CIN signature within 7 days. Sustained expression of cyclin D1KE induced mammary adenocarcinoma with similar kinetics to that of the wild-type cyclin D1. ChIP-Seq studies demonstrated recruitment of cyclin D1WT and cyclin D1KE to the genes governing CIN. We conclude that the CDK-activating function of cyclin D1 is not necessary to induce either chromosomal instability or mammary tumorigenesis.
Citation Information: Cancer Res 2013;73(24 Suppl): Abstract nr P5-07-06.
Collapse
Affiliation(s)
- RG Pestell
- Thomas Jefferson University, Philadelphia, PA; Drexel University, Philadelphia, PA; University of Conneticut, Farmington, CT; University of Manchester, Manchester, England, United Kingdom; Southwestern Medical Center, Dallas, TX
| | - MC Casimiro
- Thomas Jefferson University, Philadelphia, PA; Drexel University, Philadelphia, PA; University of Conneticut, Farmington, CT; University of Manchester, Manchester, England, United Kingdom; Southwestern Medical Center, Dallas, TX
| | - M Crosariol
- Thomas Jefferson University, Philadelphia, PA; Drexel University, Philadelphia, PA; University of Conneticut, Farmington, CT; University of Manchester, Manchester, England, United Kingdom; Southwestern Medical Center, Dallas, TX
| | - E Loro
- Thomas Jefferson University, Philadelphia, PA; Drexel University, Philadelphia, PA; University of Conneticut, Farmington, CT; University of Manchester, Manchester, England, United Kingdom; Southwestern Medical Center, Dallas, TX
| | - W Dampier
- Thomas Jefferson University, Philadelphia, PA; Drexel University, Philadelphia, PA; University of Conneticut, Farmington, CT; University of Manchester, Manchester, England, United Kingdom; Southwestern Medical Center, Dallas, TX
| | - G Di Sante
- Thomas Jefferson University, Philadelphia, PA; Drexel University, Philadelphia, PA; University of Conneticut, Farmington, CT; University of Manchester, Manchester, England, United Kingdom; Southwestern Medical Center, Dallas, TX
| | - A Ertel
- Thomas Jefferson University, Philadelphia, PA; Drexel University, Philadelphia, PA; University of Conneticut, Farmington, CT; University of Manchester, Manchester, England, United Kingdom; Southwestern Medical Center, Dallas, TX
| | - Z Yu
- Thomas Jefferson University, Philadelphia, PA; Drexel University, Philadelphia, PA; University of Conneticut, Farmington, CT; University of Manchester, Manchester, England, United Kingdom; Southwestern Medical Center, Dallas, TX
| | - EA Saria
- Thomas Jefferson University, Philadelphia, PA; Drexel University, Philadelphia, PA; University of Conneticut, Farmington, CT; University of Manchester, Manchester, England, United Kingdom; Southwestern Medical Center, Dallas, TX
| | - A Papanikolaou
- Thomas Jefferson University, Philadelphia, PA; Drexel University, Philadelphia, PA; University of Conneticut, Farmington, CT; University of Manchester, Manchester, England, United Kingdom; Southwestern Medical Center, Dallas, TX
| | - Z Li
- Thomas Jefferson University, Philadelphia, PA; Drexel University, Philadelphia, PA; University of Conneticut, Farmington, CT; University of Manchester, Manchester, England, United Kingdom; Southwestern Medical Center, Dallas, TX
| | - C Wang
- Thomas Jefferson University, Philadelphia, PA; Drexel University, Philadelphia, PA; University of Conneticut, Farmington, CT; University of Manchester, Manchester, England, United Kingdom; Southwestern Medical Center, Dallas, TX
| | - S Addya
- Thomas Jefferson University, Philadelphia, PA; Drexel University, Philadelphia, PA; University of Conneticut, Farmington, CT; University of Manchester, Manchester, England, United Kingdom; Southwestern Medical Center, Dallas, TX
| | - MP Lisanti
- Thomas Jefferson University, Philadelphia, PA; Drexel University, Philadelphia, PA; University of Conneticut, Farmington, CT; University of Manchester, Manchester, England, United Kingdom; Southwestern Medical Center, Dallas, TX
| | - P Fortina
- Thomas Jefferson University, Philadelphia, PA; Drexel University, Philadelphia, PA; University of Conneticut, Farmington, CT; University of Manchester, Manchester, England, United Kingdom; Southwestern Medical Center, Dallas, TX
| | - A Tozeren
- Thomas Jefferson University, Philadelphia, PA; Drexel University, Philadelphia, PA; University of Conneticut, Farmington, CT; University of Manchester, Manchester, England, United Kingdom; Southwestern Medical Center, Dallas, TX
| | - ES Knudsen
- Thomas Jefferson University, Philadelphia, PA; Drexel University, Philadelphia, PA; University of Conneticut, Farmington, CT; University of Manchester, Manchester, England, United Kingdom; Southwestern Medical Center, Dallas, TX
| | - A Arnold
- Thomas Jefferson University, Philadelphia, PA; Drexel University, Philadelphia, PA; University of Conneticut, Farmington, CT; University of Manchester, Manchester, England, United Kingdom; Southwestern Medical Center, Dallas, TX
| |
Collapse
|
44
|
Gounitsioti I, Poulimeneas D, Grammatikopoulou M, Tsolakidis D, Papanikolaou A, Tsigga M, Tarlatzis B. PP105-MON A PILOT STUDY ASSESSING PARAMETERS AND COMORBIDITIES DETERIORATING NUTRITIONAL STATUS IN PATIENTS WITH GYNECOLOGICAL CANCER POST-OPERATIVELY. Clin Nutr 2013. [DOI: 10.1016/s0261-5614(13)60416-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
45
|
Baliaka A, Balis G, Michalopoulou-Manoloutsiou E, Papanikolaou A, Nikolaidou A. Primary angiosarcoma of bone. A case report. Hippokratia 2013; 17:180-182. [PMID: 24376329 PMCID: PMC3743628] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/03/2023]
Abstract
BACKGROUND Primary malignant vascular tumors of bone are very rare accounting for less than 1% of primary bone malignancies. They are characterized by unknown etiology, variable biologic behavior and histological appearance. Angiosarcoma is an aggressive malignant vascular tumor derived from mesenchymal cells with endothelial differentiation. CASE REPORT We present a rare case of angiosarcoma of bone in a 47-year-old male operated for a lumbar disk herniation. During his transportation from the operation theater, a pathological intertrochanteric fracture of the right hip occured. The magnetic resonance imaging (MRI) revealed a bone lytic lesion located into the great trochanter of the right femur. Open surgical biopsy of the lesion was performed and the histological examination showed primary angiosarcoma of bone. The treatment included radiotherapy (300 cGy per fraction in 13 days) followed by excision of the proximal femur and custom made total hip arthroplasty. The diagnosis was confirmed on the surgical specimen.
Collapse
Affiliation(s)
- A Baliaka
- Department of Pathology, Cancer Hospital of Thessaloniki "Theagenio"
| | - Gc Balis
- Department of Pathology, Cancer Hospital of Thessaloniki "Theagenio"
| | | | - A Papanikolaou
- Department of Pathology, General Hospital of Thessaloniki "G.Gennimatas", Thessaloniki, Greece
| | - A Nikolaidou
- Department of Pathology, Cancer Hospital of Thessaloniki "Theagenio"
| |
Collapse
|
46
|
Smirnakis SM, Keliris GA, Shao Y, Papanikolaou A, Logothetis NK. Population receptive field measurements in macaque visual cortex. J Vis 2012. [DOI: 10.1167/12.9.1397] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
47
|
Georgiou M, Patapatiou G, Domoxoudis S, Pistevou-Gompaki K, Papanikolaou A. Oral Mucositis: understanding the pathology and management. Hippokratia 2012; 16:215-216. [PMID: 23935285 PMCID: PMC3738725] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/02/2023]
Abstract
Oral Mucositis is a common complication of cancer therapy which may limit the completion of treatment and affect the quality of life of the patient. As we have come to understand its pathogenesis new developments in its management and prevention have allowed us minimize this side effect.
Collapse
Affiliation(s)
- M Georgiou
- Radiation Oncology Department, AHEPA University Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece
| | | | | | | | | |
Collapse
|
48
|
Tsolakidis D, Papanikolaou A, Ktenidis K, Pervana S. Primary ovarian small cell carcinoma of pulmonary type with enlarged paraaortic lymph node masses: a case report and review of the literature. EUR J GYNAECOL ONCOL 2012; 33:312-315. [PMID: 22873108] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/01/2023]
Abstract
INTRODUCTION Small cell carcinoma of the ovary of pulmonary type, is a rare, aggressive tumour with poor prognosis and its optimal management is unclear. CASE PRESENTATION A 55-year-old Caucasian woman presented with abdominal discomfort and left lumbar pain within a three-week period. At exploratory laparotomy, a 8 cm solid cystic mass of the left ovary was found infiltrating the sigmoid colon, and a bulky mass (11 x 7 x 4 cm) in the left paraaortic infrarenal region. Histopathological features resembling small cell carcinoma of the lungs and positive immunohistochemical stains provided a definite diagnosis of IIIC ovarian small cell carcinoma of pulmonary type. After six cycles chemotherapy with carboplatin and etoposide, the patient is still alive at 21 months from initial diagnosis. DISCUSSION In this case, the absence of peritoneal involvement and the extensive paraaortic adenopathy is suggestive of a different pattern of spread of this rare tumour. Optimal treatment seems to be radical primary debulking surgery resulting in no residual disease, maximizing the effect of adjuvant chemotherapy for this biological aggressive tumour.
Collapse
Affiliation(s)
- D Tsolakidis
- First Department of Obstetrics and Gynaecology, "Papageorgiou" General Hospital, Aristotle University of Thessaloniki, Greece.
| | | | | | | |
Collapse
|
49
|
Makedos A, Goulis DG, Arvanitidou M, Mintziori G, Papanikolaou A, Makedou A, Panidis D. Increased serum C-reactive protein levels in normal weight women with polycystic ovary syndrome. Hippokratia 2011; 15:323-326. [PMID: 24391413 PMCID: PMC3876847] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/03/2023]
Abstract
BACKGROUND The clinical spectrum of polycystic ovary syndrome (PCOS) includes components of the metabolic syndrome, such as central obesity, insulin resistance, dyslipidemia, arterial hypertension and, even, disturbances of the clotting mechanism. All these disorders are epidemiologically related to cardiovascular disease, most probably through low-grade intravascular chronic inflammation. The aim of this study was to evaluate the serum concentrations of high sensitivity C-reactive protein (hsCRP), a non-specific marker of low-grade inflammation and a predictive marker for cardiovascular disease, in normal weight women with (PCOS). PATIENTS AND METHODS One hundred and eighty-eight (188) normal weight [body mass index (BMI) < 25 kg/m(2)] women with PCOS were included in the study. Forty-three (43) normal weight women without PCOS (normal ovulation without clinical or biochemical hyperandrogenemia) served as controls. Serum samples for luteinizing hormone, folliclestimulating hormone, prolactin, total testosterone, Δ4-androstenedione, 17α-hydroxy-progesterone, sex hormone-binding globulin (SHBG), insulin, glucose and hsCRP were collected in early follicular phase (third to sixth day) of a menstrual cycle in the control group or during a spontaneous bleeding episode in the PCOS group. RESULTS Normal weight women with PCOS had higher concentrations of serum hsCRP as compared to normal weight women without PCOS (mean ± standard error of the mean 0.55 ± 0.08 versus 0.27 ± 0.08 mg/dL, p = 0.001). CONCLUSIONS As normal weight women with PCOS are characterized by elevated serum concentrations of hsCRP, they have to be considered as carrying at least one marker of low-grade inflammation.
Collapse
Affiliation(s)
- A Makedos
- Unit of Reproductive Endocrinology and Human Reproduction, Second Department of Obstetrics and Gynecology, Aristotle University of Thessaloniki, Greece
| | - D G Goulis
- Unit of Reproductive Endocrinology, First Department of Obstetrics and Gynecology, Aristotle Universityof Thessaloniki, Greece
| | - M Arvanitidou
- Department of Hygiene, Medical School, Aristotle University of Thessaloniki, Greece
| | - G Mintziori
- Unit of Reproductive Endocrinology, First Department of Obstetrics and Gynecology, Aristotle Universityof Thessaloniki, Greece
| | - A Papanikolaou
- Unit of Reproductive Endocrinology, First Department of Obstetrics and Gynecology, Aristotle Universityof Thessaloniki, Greece
| | - A Makedou
- Unit of Reproductive Endocrinology and Human Reproduction, Second Department of Obstetrics and Gynecology, Aristotle University of Thessaloniki, Greece
| | - D Panidis
- Unit of Reproductive Endocrinology and Human Reproduction, Second Department of Obstetrics and Gynecology, Aristotle University of Thessaloniki, Greece
| |
Collapse
|
50
|
Affiliation(s)
- Konstantinos Liapis
- Department of Hematology, Sismanogleio Hospital, Athens Department of Hematopathology, Evangelismos Hospital, 1 Sismanogleiou Street, Athens, Greece.
| | | | | | | | | |
Collapse
|